Search research articles
Contact Us
Filters
Showing results (31-40 of 34) with videos related to
Page
of 4
Sort By:
You have reached the last page of results.
This site can display upto 34 results.
Respirology (Carlton, Vic.)
|
November 13, 2024
Environmental impact of inhaled medicines: A Thoracic Society of Australia and New Zealand position statement
Danielle F Wurzel, Brett D Montgomery, Natalie Anderson, et al.
Respirology (Carlton, Vic.)
|
September 29, 2021
Oral corticosteroids stewardship for asthma in adults and adolescents: A position paper from the Thoracic Society of Australia and New Zealand
John Blakey, Li Ping Chung, Vanessa M McDonald, et al.
Human Genetics
|
March 31, 2006
Genetic variation at the growth hormone (GH1) and growth hormone receptor (GHR) loci as a risk factor for hypertension and stroke
Martin Horan, Vicky Newsway, Yasmin, et al.
Respiratory Medicine
|
September 5, 2025
Mepolizumab treatment and reduced oral corticosteroid exposure improves symptoms of depression and anxiety in severe eosinophilic asthma: data from the Australian Mepolizumab Registry
Erin S Harvey, Yuto Hamada, Sarah A Hiles, et al.
Page
of 4
Search research articles
Search
Showing results (31-40 of 34) with videos related to
Sort By:
Page
of 4
You have reached the last page of results.
This site can display upto 34 results.
Respirology (Carlton, Vic.)
|
November 13, 2024
Environmental impact of inhaled medicines: A Thoracic Society of Australia and New Zealand position statement
Danielle F Wurzel, Brett D Montgomery, Natalie Anderson, et al.
Respirology (Carlton, Vic.)
|
September 29, 2021
Oral corticosteroids stewardship for asthma in adults and adolescents: A position paper from the Thoracic Society of Australia and New Zealand
John Blakey, Li Ping Chung, Vanessa M McDonald, et al.
Human Genetics
|
March 31, 2006
Genetic variation at the growth hormone (GH1) and growth hormone receptor (GHR) loci as a risk factor for hypertension and stroke
Martin Horan, Vicky Newsway, Yasmin, et al.
Respiratory Medicine
|
September 5, 2025
Mepolizumab treatment and reduced oral corticosteroid exposure improves symptoms of depression and anxiety in severe eosinophilic asthma: data from the Australian Mepolizumab Registry
Erin S Harvey, Yuto Hamada, Sarah A Hiles, et al.
Page
of 4